Levitra (Vardenafil, BAY38-9456)

ApprovedCompleted

0 watching 0 views this week🔥 Hot

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

✓

Phase 3

Approved

Indication / Disease

Erectile Dysfunction

Conditions

Erectile Dysfunction

Trial Timeline

Sep 1, 2003 → Jun 1, 2004

NCT ID

NCT00662441

About Levitra (Vardenafil, BAY38-9456)

Levitra (Vardenafil, BAY38-9456) is a approved stage product being developed by Bayer for Erectile Dysfunction. The current trial status is completed. This product is registered under clinical trial identifier NCT00662441. Target conditions include Erectile Dysfunction.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (8)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00874679	Pre-clinical	Completed	Mar 1, 2007	Apr 1, 2010	Erectile Dysfunction
NCT00470873	Pre-clinical	Completed	Jan 1, 2007	Feb 1, 2008	Erectile Dysfunction
NCT00652262	Phase 3	Completed	Mar 1, 2004	Nov 1, 2004	Erectile Dysfunction
NCT00663598	Approved	Completed	Oct 1, 2003	Sep 1, 2004	Erectile Dysfunction
NCT00662441	Approved	Completed	Sep 1, 2003	Jun 1, 2004	Erectile Dysfunction
NCT00654914	Phase 3	Completed	May 1, 2003	Feb 1, 2004	Erectile Dysfunction
NCT00681772	Approved	Completed	Mar 1, 2003	Nov 1, 2003	Erectile Dysfunction
NCT00668018	Phase 3	Completed	Jan 1, 2003	Oct 1, 2003	Erectile Dysfunction

Competing Products

20 competing products in Erectile Dysfunction

See all competitors

Product	Company	Stage	Hype Score
tadalafil + placebo	Eli Lilly	Phase 3	77
YHD1023 + YHD1023 + YHD1023 + Cialis + Placebo	Yuhan	Phase 2	52
Tacrolimus + Placebo	Astellas Pharma	Approved	85
Mirabegron	Astellas Pharma	Phase 1/2	41
LY2452473 + Tadalafil + LY900010	Eli Lilly	Phase 1	33
tadalafil + placebo	Eli Lilly	Phase 3	77
tadalafil	Eli Lilly	Phase 3	77
LY2452473 + tadalafil + placebo (tadalafil) + placebo (LY2452473)	Eli Lilly	Phase 2	52
Tadalafil	Eli Lilly	Approved	85
tadalafil + placebo	Eli Lilly	Approved	85
Tadalafil + Sildenafil Citrate	Eli Lilly	Approved	85
Tadalafil + Placebo	Eli Lilly	Phase 3	77
Placebo + Tadalafil	Eli Lilly	Approved	85
Tadalafil + Placebo	Eli Lilly	Approved	85
tadalafil	Eli Lilly	Approved	85
Tadalafil + Sildenafil	Eli Lilly	Approved	85
tadalafil once a day [T(OaD)] + sildenafil citrate as needed [S(PRN)] + tadalafil as needed [T(PRN)]	Eli Lilly	Phase 3	77
Tadalafil + Placebo	Eli Lilly	Approved	85
Dapoxetine	Johnson & Johnson	Phase 3	77
dapoxetine	Johnson & Johnson	Phase 3	77

Other Products from Bayer

TelmisartanApproved

Clotrimazole vaginal tablet + FluconazoleApproved

Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved

Rivaroxaban 20 MG + WarfarinApproved

AcarboseApproved